ketoconazole has been researched along with Spinal Cord Diseases in 1 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Spinal Cord Diseases: Pathologic conditions which feature SPINAL CORD damage or dysfunction, including disorders involving the meninges and perimeningeal spaces surrounding the spinal cord. Traumatic injuries, vascular diseases, infections, and inflammatory/autoimmune processes may affect the spinal cord.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Winston, DJ | 1 |
| Kurtz, TO | 1 |
| Fleischmann, J | 1 |
| Morgan, D | 1 |
| Batzdorf, U | 1 |
| Stern, WE | 1 |
1 other study available for ketoconazole and Spinal Cord Diseases
| Article | Year |
|---|---|
Successful treatment of spinal arachnoiditis due to coccidioidomycosis. Case report.
Topics: Adult; Amphotericin B; Arachnoiditis; Coccidioidomycosis; Humans; Imidazoles; Ketoconazole; Male; Pi | 1983 |